Talaris Therapeutics, Inc. announced the appointment of Mary Kay Fenton as Chief Financial Officer. Ms. Fenton has over 25 years of operational and transactional experience in the biotechnology industry. Prior to joining Talaris, Ms. Fenton served as Vice President, Strategic Operations for the Cell and Genetic Therapies unit at Vertex Pharmaceuticals. Before that role, she was the Chief Financial Officer and Chief Operating Officer of Semma Therapeutics. Ms. Fenton joined Semma Therapeutics from Achillion Pharmaceuticals, where she served as Chief Financial Officer from 2006 to 2018. Ms. Fenton currently serves as Audit Committee Chair on the Board of Directors at Oncorus Inc.